Nebula Biocides develops Sporosan®, a disinfection solution utilizing a two-component system based on peroxynitrous acid that effectively inactivates bacterial spores and viruses within one minute, even in the presence of organic matter. This technology addresses the persistent contamination of surfaces in healthcare settings, particularly from resistant pathogens like Clostridioides difficile, which can lead to severe infections and increased healthcare costs.
Funding
$1.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Healthcare settings face persistent surface contamination, particularly from resistant pathogens like Clostridioides difficile, which can survive standard disinfection methods and lead to severe infections, increased hospital stays, and higher healthcare costs. Bacterial spores are especially resilient, resisting alcohol and steam disinfection, and can remain viable on surfaces for months.
Solution
Nebula Biocides offers Sporosan®, a two-component disinfection system based on peroxynitrous acid, designed for rapid inactivation of bacterial spores, viruses, and other pathogens. The solution is effective within one minute, even in the presence of organic matter, making it suitable for both surface disinfection and medical device reprocessing. Sporosan's active ingredient is generated in situ when the two components are combined, ensuring a potent and readily available disinfectant. After disinfection, the active ingredient decomposes into harmless residues and water.
Target Audience
The primary target audience includes hospitals, clinics, and other healthcare facilities seeking a fast-acting, broad-spectrum disinfectant to combat persistent and resistant pathogens, as well as manufacturers of automated disinfection equipment.
Features
- Utilizes peroxynitrous acid for broad-spectrum disinfection.
- Kills spores in under 1 minute, even with high organic load.
- Available as a concentrate, tablet, or ready-to-use solution.
- Can be adapted for automated disinfection systems.
- Effective against MRSA (EN 13727), viruses including Coronavirus (EN 14476), and fungi (EN 13624).
- Sporicidal efficacy demonstrated against Clostridioides difficile (prEN 17126).
- Can be produced on-site from concentrates.
- Being developed as a salt-based solid for easier handling and reduced transport volume.